| Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I-TAC | cis | Discovery | rs4356932 | 4:76,955,194 | C/T | 0.45 | 993 | 0.329 | 0.043 | 4.3×10-14 | 1.170 | 1.4×10-11 | 0.012 |
| I-TAC | cis | Replication | rs10003382 | 4:76,955,473 | A/G | 0.40 | 337 | 0.207 | 0.067 | 0.002 | 1.130 | 0.004 | 0.01 |
| Target (abbrv.) | I-TAC |
| Target (full name) | C-X-C motif chemokine 11 |
| Somalogic ID (Sequence ID) | SL003326 (3038-9_2) |
| Entrez Gene Symbol | CXCL11 |
| UniProt ID | O14625 |
| UniProt Comment |
|
| Wiki Pathways |
|
| Pathway Interaction Database |
|
| Reactome |
|
| Pathway Studio |
|
All locus annotations are based on the sentinel SNP (rs4356932) and 264 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
| Genes hit or close-by |
|
| Potentially regulated genes |
|
| eQTL genes |
| Trait | P | Study | Source |
|---|---|---|---|
| cg11525552 (chr4:76932165) | 5.2×10-101 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
| cg04038163 (chr4:76925179) | 1.7×10-90 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
| Gene expression of NAAA in blood | 8.3×10-84 | 21829388 (PMID) | GRASP2 eQTL |
| Gene expression of ASAHL in peripheral blood monocytes | 6.7×10-43 | 20502693 (PMID) | GRASP2 eQTL |
| cg05110901 (chr4:76931542) | 1.9×10-29 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
| Gene expression of NAAA [probe 214765_s_at] in lymphoblastoid cell lines | 1.4×10-23 | 17873877 (PMID) | GRASP2 eQTL |
| Gene expression of ASAHL in lymphoblastoid cell lines | 1.1×10-21 | 17873877 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA [probe 227135_at] in lymphoblastoid cell lines | 7.3×10-21 | 17873877 (PMID) | GRASP2 eQTL |
| Gene expression of CXCL10 in peripheral blood monocytes | 7.3×10-16 | 20502693 (PMID) | GRASP2 eQTL |
| cg24979437 (chr4:76932155) | 2.4×10-13 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
| Gene expression of ASAHL in CEU-CHB-JPT-YRI lymphoblastoid cell lines | 1.8×10-12 | 17873874 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA (probeID ILMN_1668605) in cerebellum in Alzheimer's disease cases and controls | 2.8×10-11 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA (probeID ILMN_2391512) in cerebellum in Alzheimer's disease cases and controls | 9.4×10-11 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of CXCL9 in peripheral blood monocytes | 1.1×10-9 | 20502693 (PMID) | GRASP2 eQTL |
| Gene expression of CXCL10 [probe 204533_at] in lymphoblastoid cell lines | 2.6×10-9 | 17873877 (PMID) | GRASP2 eQTL |
| Gene expression of ASAHL in blood cells in Celiac disease | 5.6×10-9 | 19128478 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA (probeID ILMN_2285568) in cerebellum in Alzheimer's disease cases and controls | 1.1×10-8 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of CXCL10 in lymphoblastoid cell lines | 2×10-8 | 17873877 (PMID) | GRASP2 eQTL |
| Gene expression of ASAHL in YRI lymphoblastoid cell lines | 3.9×10-8 | 17873874 (PMID) | GRASP2 eQTL |
| Serum ratio of (1-heptadecanoylglycerophosphocholine)/(biliverdin) | 7.6×10-7 | 21886157 (PMID) | GRASP2 metabQTL |
| Gene expression of NAAA (probeID ILMN_1668605) in cerebellum in Alzheimer's disease cases | 1.2×10-6 | 22685416 (PMID) | GRASP2 eQTL |
| cg09020375 (chr4:76995518) | 1.2×10-5 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
| Gene expression of NAAA (probeID ILMN_1668605) in cerebellum in non-Alzheimer's disease samples | 3×10-5 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA (probeID ILMN_2285568) in temporal cortex in Alzheimer's disease cases and controls | 4.1×10-5 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA (probeID ILMN_2391512) in temporal cortex in Alzheimer's disease cases and controls | 9.8×10-5 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA (probeID ILMN_1668605) in temporal cortex in Alzheimer's disease cases | 1.1×10-4 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of CXCL10 in blood | 1.4×10-4 | 21829388 (PMID) | GRASP2 eQTL |
| Autism | 1.4×10-4 | 20663923 (PMID) | GRASP2 nonQTL |
| Gene expression of CXCL10 (ENSG00000169245) in dendritic cells treated with Mycobacterium tuberculosis | 1.6×10-4 | 22233810 (PMID) | GRASP2 eQTL |
| Gene expression of NAAA (probeID ILMN_1668605) in temporal cortex in Alzheimer's disease cases and controls | 1.8×10-4 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of ASAHL [probe 2773872] in peripheral blood mononuclear cells | 3×10-4 | 19222302 (PMID) | GRASP2 eQTL |
| Alzheimer's disease | 3.4×10-4 | 24162737 (PMID) | Supplemental file |